Document is current
Any future updates will be listed below
-
Authors
Si, Shuqing http://orcid.org/0009-0006-6095-254X
Bi, Anbreen
Yu, Zhaoying
See, Cheryl http://orcid.org/0000-0003-2135-5495
Kelly, Sinead
Ambrogi, Sonia http://orcid.org/0000-0002-2897-358X
Arango, Celso http://orcid.org/0000-0003-3382-4754
Baeza, Inmaculada
Banaj, Nerisa http://orcid.org/0000-0002-6317-8549
Berk, Michael
Castro-Fornieles, Josefina http://orcid.org/0000-0003-0632-2687
Crespo-Facorro, Benedicto
Crouse, Jacob J. http://orcid.org/0000-0002-3805-2936
Díaz-Caneja, Covadonga M. http://orcid.org/0000-0001-8538-3175
Fett, Anne-Kathrin http://orcid.org/0000-0003-0282-273X
Fortea, Adriana http://orcid.org/0000-0003-3681-0841
Frangou, Sophia
Goldstein, Benjamin I.
Hickie, Ian B. http://orcid.org/0000-0001-8832-9895
Janssen, Joost http://orcid.org/0000-0001-7613-2067
Kennedy, Kody G. http://orcid.org/0000-0002-4510-188X
Krabbendam, Lydia
Kyriakopoulos, Marinos
MacIntosh, Bradley J. http://orcid.org/0000-0001-7300-2355
Morgado, Pedro http://orcid.org/0000-0003-3880-3258
Nerland, Stener http://orcid.org/0000-0001-8771-8856
Pascual-Diaz, Saül http://orcid.org/0000-0001-5871-5867
Picó-Pérez, Maria http://orcid.org/0000-0002-1573-2445
Piras, Fabrizio http://orcid.org/0000-0003-3566-5494
Rund, Bjørn Rishovd
de la Serna, Elena
Spalletta, Gianfranco
Sugranyes, Gisela http://orcid.org/0000-0002-2545-7862
Suo, Chao http://orcid.org/0000-0002-9358-6690
Tordesillas-Gutiérrez, Diana
Vecchio, Daniela http://orcid.org/0000-0001-8428-7376
Radua, Joaquim
McGuire, Philip http://orcid.org/0000-0003-4381-0532
Thomopoulos, Sophia I.
Jahanshad, Neda
Thompson, Paul M.
Barth, Claudia http://orcid.org/0000-0001-6544-0945
Agartz, Ingrid
James, Anthony http://orcid.org/0000-0002-2742-8328
Kempton, Matthew J. http://orcid.org/0000-0003-3541-9947
- License Information
-
More Information
Article History
Received: 13 June 2023
Revised: 7 November 2023
Accepted: 27 November 2023
First Online: 10 January 2024
Competing interests
: PT and NJ were funded in part by Biogen, Inc., for research unrelated to this manuscript. GS has received speaker fees from Angelini Pharma for a topic unrelated to this manuscript. AF has received educational support from Otsuka-Lundbeck, Janssen Cilag and Rovi, unrelated to this manuscript. CA has been a consultant to or has received honoraria or grants from Acadia, Angelini, Biogen, Boehringer, Gedeon Richter, Janssen Cilag, Lundbeck, Medscape, Menarini, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering Plow, Sumitomo Dainippon Pharma, Sunovion and Takeda. CDC has received honoraria from Exeltis and Angelini unrelated to this manuscript. IB has received honoraria and travel support from Angelini, Otsuka-Lundbeck and Janssen. IA has received speaker’s honorarium from Lundbeck. PM has received in the past 3 years grants, CME-related honoraria, or consulting fees from Angelini, AstraZeneca, Bial, Biogen, DGS-Portugal, FCT, FLAD, Janssen-Cilag, Gulbenkian Foundation, Lundbeck, Springer Healthcare, Tecnimede, Viatris and 2CA-Braga. IBH is the Co-Director, Health and Policy at the Brain and Mind Centre (BMC) University of Sydney, Australia. The BMC operates an early-intervention youth service at Camperdown under contract to headspace. IBH has previously led community-based and pharmaceutical industry-supported (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca, Janssen Cilag) projects focused on the identification and better management of anxiety and depression. He is the Chief Scientific Advisor to, and a 3.2% equity shareholder in, InnoWell Pty Ltd, which aims to transform mental health services through the use of innovative technologies.
